Andrew Smith
Direttore Finanziario/CFO presso SANTHERA PHARMACEUTICALS HOLDING AG
Profilo
Andrew Smith is an accomplished executive leader with over 30 years’ international experience within the bio-pharma sector.
He currently serves as Chief Financial Officer for Santhera Pharmaceuticals AG, a global specialty pharmaceutical company focused on developing medicines for rare diseases.
Before joining Santhera he held the roles of CFO and COO Allecra Therapeutics GmbH and CFO at Sucampo Pharmaceuticals Inc..
Together with previous senior financial and operations roles focusing on business improvement and transformation he has gained significant exposure to European and US markets working in public and private organizations with a focus on start-ups, spinoffs and growth and has been involved in a number of capital market transactions in excess of USD 700 million.
Andrew is a Fellow of the Chartered Institute of Management Accountants and a Chartered Global Management Accountant.
He studied business and accounting at Liverpool John Moores University and Durham University Business School.
Andrew joined the Arix Board in August 2022 and is Chair of the Audit Committee and a member of the Nomination Committee.
Posizioni attive di Andrew Smith
| Società | Posizione | Inizio |
|---|---|---|
| SANTHERA PHARMACEUTICALS HOLDING AG | Direttore Finanziario/CFO | 01/04/2020 |
| ARIX BIOSCIENCE PLC | Direttore/Membro del Consiglio | 10/08/2022 |
Sucampo Pharma Europe Ltd.
 Sucampo Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Mallinckrodt Plc, Sucampo Pharma Europe Ltd. is a British company that develops therapies for gastrointestinal, circulatory, and ophthalmic diseases. The company is based in London, UK. Sucampo Pharma Europe was acquired by Sucampo Pharmaceuticals LLC, part of Mallinckrodt Plc from February 14, 2018 on September 28, 2006. | Direttore Finanziario/CFO | 10/03/2011 |
Sucampo GmbH
 Sucampo GmbH Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Sucampo GmbH is a Swiss company that manufactures and distributes pharmaceuticals and health care products. The company is based in Zug, Switzerland. The company was founded by Ryuji Ueno, Sachiko Kuno. Sucampo was acquired by Sucampo Pharmaceuticals LLC, part of Mallinckrodt Plc from February 14, 2018 on December 29, 2010 for $120 million. | Direttore Finanziario/CFO | 28/06/2012 |
1-800 Contacts, Inc.
 1-800 Contacts, Inc. Specialty StoresRetail Trade 1-800 Contacts, Inc. retails and sells contact lenses. Its products include disposable contact lenses, toric, color, bifocal lenses and accessories. The firm offers all brands of contact lenses and also offers eyeglasses and sunglasses. The company was founded by Jonathan C. Coon and John F. Nichols in 1995 and is headquartered in Orem, UT. | Direttore Finanziario/CFO | - |
Santhera Pharmaceuticals (USA), Inc.
 Santhera Pharmaceuticals (USA), Inc. Pharmaceuticals: MajorHealth Technology Santhera Pharmaceuticals (USA), Inc. engages in the provision of regulatory and medical services. The company is headquartered in Burlington, MA. | Direttore/Membro del Consiglio | - |
Arix Bioscience /Venture Capital/
 Arix Bioscience /Venture Capital/ Investment ManagersFinance Arix Bioscience /Venture Capital/ (Arix Bioscience) is a venture capital subsidiary of Arix Bioscience Plc founded in 2015 by Christopher Thomas Evans, Jonathan M. Peacock and Joseph Anderson. The firm is headquartered in London, United Kingdom with an additional offices in New York. | Direttore/Membro del Consiglio | 01/08/2022 |
Precedenti posizioni note di Andrew Smith
| Società | Posizione | Fine |
|---|---|---|
| SUCAMPO PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 20/03/2017 |
hVIVO Services Ltd.
 hVIVO Services Ltd. Internet Software/ServicesTechnology Services Part of hVIVO PLC, hVIVO Services Ltd. is a British company that specializes in full-service viral challenge studies. The company is based in London, UK. The company's services include challenge models and lab services. The company was founded in 1988 by John Sidney Oxford. | Direttore Finanziario/CFO | 01/01/2009 |
| ░░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░ | - |
| ░░░░ ░░░░░░░ ░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
Formazione di Andrew Smith
| University of Durham | Doctorate Degree |
| Liverpool John Moores University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| SANTHERA PHARMACEUTICALS HOLDING AG | Health Technology |
| ARIX BIOSCIENCE PLC | Finance |
| Aziende private | 10 |
|---|---|
Sucampo Pharmaceuticals, Inc.
 Sucampo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products. The company was founded by Ryuji Ueno and Sachiko Kuno on December 5, 1996 and is headquartered in Bethesda, MD. | Health Technology |
Sucampo Pharma Europe Ltd.
Sucampo Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Mallinckrodt Plc, Sucampo Pharma Europe Ltd. is a British company that develops therapies for gastrointestinal, circulatory, and ophthalmic diseases. The company is based in London, UK. Sucampo Pharma Europe was acquired by Sucampo Pharmaceuticals LLC, part of Mallinckrodt Plc from February 14, 2018 on September 28, 2006. | Commercial Services |
Sucampo GmbH
Sucampo GmbH Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Sucampo GmbH is a Swiss company that manufactures and distributes pharmaceuticals and health care products. The company is based in Zug, Switzerland. The company was founded by Ryuji Ueno, Sachiko Kuno. Sucampo was acquired by Sucampo Pharmaceuticals LLC, part of Mallinckrodt Plc from February 14, 2018 on December 29, 2010 for $120 million. | Health Technology |
Tech Council of Maryland, Inc.
 Tech Council of Maryland, Inc. Miscellaneous Commercial ServicesCommercial Services Tech Council of Maryland, Inc. provides membership association services for technology and life science communities. The firm serves the advanced technology and biotechnology communities. The company was founded in 1986 and is headquartered in Rockville, MD. | Commercial Services |
hVIVO Services Ltd.
hVIVO Services Ltd. Internet Software/ServicesTechnology Services Part of hVIVO PLC, hVIVO Services Ltd. is a British company that specializes in full-service viral challenge studies. The company is based in London, UK. The company's services include challenge models and lab services. The company was founded in 1988 by John Sidney Oxford. | Technology Services |
1-800 Contacts, Inc.
1-800 Contacts, Inc. Specialty StoresRetail Trade 1-800 Contacts, Inc. retails and sells contact lenses. Its products include disposable contact lenses, toric, color, bifocal lenses and accessories. The firm offers all brands of contact lenses and also offers eyeglasses and sunglasses. The company was founded by Jonathan C. Coon and John F. Nichols in 1995 and is headquartered in Orem, UT. | Retail Trade |
Allecra Therapeutics GmbH
 Allecra Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Allecra Therapeutics GmbH focuses on the development of novel treatments to combat multi drug-resistant bacterial infections. The firm serves the bio and pharmaceutical industry. The company was founded by Nicholas Benedict and Stuart Shapiro in 2013 and is headquartered in Weil am Rhein, Germany. | Health Technology |
Santhera Pharmaceuticals (USA), Inc.
Santhera Pharmaceuticals (USA), Inc. Pharmaceuticals: MajorHealth Technology Santhera Pharmaceuticals (USA), Inc. engages in the provision of regulatory and medical services. The company is headquartered in Burlington, MA. | Health Technology |
| Clearlab Europe Ltd. | |
Arix Bioscience /Venture Capital/
Arix Bioscience /Venture Capital/ Investment ManagersFinance Arix Bioscience /Venture Capital/ (Arix Bioscience) is a venture capital subsidiary of Arix Bioscience Plc founded in 2015 by Christopher Thomas Evans, Jonathan M. Peacock and Joseph Anderson. The firm is headquartered in London, United Kingdom with an additional offices in New York. | Finance |
- Borsa valori
- Insiders
- Andrew Smith
